fbpx

December 2020 Newsletter

Home/Diabetes Bites/December 2020 Newsletter

Updated Label of Liraglutide for Obesity in Adolescents

The use of a GLP-1 receptor agonist for adolescents aged 12-17 years and adults who are struggling with uncontrollable hunger and/obesity has been FDA approved.

By |2020-12-17T19:16:19+00:00December 15th, 2020|Categories: December 2020 Newsletter, Diabetes Bites|0 Comments

High HbA1c increases risks for acute respiratory distress syndrome with COVID-19

A retrospective study of 77 severely or critically ill adults was done, considering a “high” A1c of anything over 6.5%.

By |2020-12-15T17:29:26+00:00December 14th, 2020|Categories: December 2020 Newsletter, Diabetes Bites|0 Comments
Go to Top